[Therapeutic possibilities in idiopathic headaches. Analysis of about 1000 cases].
This work is an attempt to find an answer to the question: once arrived at the diagnostic identification of a certain type of idiopathic headache, which treatment should be followed? On the basis of recent researches and experience acquired during ten years' activity of our Headache Unit, a diagnostic identification can be made for migraine (in all its types and evolution stages), cluster headache, tension headache and pure psycogenic headache. Among the most widely used drugs, positive pharmacological results were obtained with: cyproheptadine, pizotifen, cinnarizine, lysergic acid derivatives, histamine, reserpine, clonidine and a barbituric acid derivative. The therapeutic cycles were standardized, for each drug, in the way of administration, dosage and total duration of the treatment. A comparison between the data obtained and the pre-therapeutic situation was made. When repeated, the most efficacious therapeutic cycle was evaluated. According to Pearson's dispersion index, each group of patients improved respresents 16.68% of the expected total results (frequency of attacks reduced to 50%, 25% and 0%): for cyproheptadine, pizotifen, methysergide, histamine, clonidine and allil-propyl-malonylurea, the "p" is less than 0.001; for cinnarizine, less than 0.02. This "a posteriori" analysis does not take into account the placebo control, the "anticipation effect", and the "carry over effect". It cannot therefore be a comparison of efficacy among the various drugs. An evaluation based on "among patients" and "inside patient" method by means of the cross over system, can instead give some useful suggestion about which treatment is to be recommended to patients suffering from recurrent headaches. With regard to migraine sufferers: cinnarizine, cyproheptadine, clonidine, histamine, pizotifen und reserpine. For cluster headaches: cinnarizine, cyproheptadine, clonidine, histamine and reserpine. For tension headaches: cyproheptadine. For pure psychogenic headache: allyl-propyl-malonylurea. For migraine attacks or parossystic crises in the course of ondulating or continuous headaches, positive therapeutic results, statistically significant, were obtained with an association of indomethacin, caffeine and prochlorperazine.
D002936:Cinnarizine / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D006261:Headache / Q000188:drug therapy*; D006632:Histamine / Q000627:therapeutic use; D006801:Humans; D008784:Methysergide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D010918:Pizotyline / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use; D014653:Vascular Headaches / Q000188:drug therapy
D008996:Monoamine Oxidase Inhibitors; D010455:Peptides; D010918:Pizotyline; D003533:Cyproheptadine; D002936:Cinnarizine; D006632:Histamine; D012110:Reserpine; D014508:Urea; D003000:Clonidine; D008784:Methysergide
Possibilità terapeutiche per le cefalee idiopatiche. Analisi di circa 1000 casi